Immune checkpoints, such as program death ligand1/2 (PD-L1/L2), galectin-9 (GAL-9), and CD80/86 (also known as B7-1/2), are commonly seen in tumor cells, tumor associated macrophages, DCs, and MDSCs. This evidence concerns the gene CD80 and neoplasm.